Uri Ladabaum

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi When even people at high risk do not take up colorectal cancer screening
    Uri Ladabaum
    Division of Gastroenterology, University of California. 513 Parnassus Ave, San Francisco, USA
    Gut 56:1648-50. 2007
  2. ncbi Gastric fundic distension activates fronto-limbic structures but not primary somatosensory cortex: a functional magnetic resonance imaging study
    Uri Ladabaum
    Division of Gastroenterology, S 357, Box 0538, University of California, San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143 0538, and The Children s Hospital of Philadelphia, PA 19104, USA
    Neuroimage 34:724-32. 2007
  3. ncbi Citalopram provides little or no benefit in nondepressed patients with irritable bowel syndrome
    Uri Ladabaum
    Division of Gastroenterology, University of California, San Francisco, California Department of Medicine, University of California, San Francisco, California, USA
    Clin Gastroenterol Hepatol 8:42-48.e1. 2010
  4. ncbi Colorectal cancer screening differential costs for younger versus older Americans
    Uri Ladabaum
    Division of Gastroenterology, University of California San Francisco, 94143 0538, USA
    Am J Prev Med 30:378-84. 2006
  5. ncbi Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand
    Uri Ladabaum
    Division of Gastroenterology, University of California, San Francisco, 94143, USA
    Gastroenterology 129:1151-62. 2005
  6. ncbi Trends in colonoscopy for colorectal cancer screening
    Kathryn A Phillips
    University of California, San Francisco, CA 94143, USA
    Med Care 45:160-7. 2007
  7. ncbi Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis
    Kenneth Song
    Department of Medicine, Division of Gastroenterology, University of California-San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143-0538, USA
    Gastroenterology 126:1270-9. 2004
  8. ncbi Preferences for outcomes associated with decisions to undergo or forgo genetic testing for Lynch syndrome
    Miriam Kuppermann
    Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, USA
    Cancer 119:215-25. 2013
  9. ncbi Diagnosis, comorbidities, and management of irritable bowel syndrome in patients in a large health maintenance organization
    Uri Ladabaum
    Division of Gastroenterology, Stanford University, Stanford, California, USA
    Clin Gastroenterol Hepatol 10:37-45. 2012
  10. ncbi Colorectal neoplasia screening with virtual colonoscopy: when, at what cost, and with what national impact?
    Uri Ladabaum
    Department of Medicine, University of California, San Francisco, 94143 0538, USA
    Clin Gastroenterol Hepatol 2:554-63. 2004

Collaborators

Detail Information

Publications28

  1. ncbi When even people at high risk do not take up colorectal cancer screening
    Uri Ladabaum
    Division of Gastroenterology, University of California. 513 Parnassus Ave, San Francisco, USA
    Gut 56:1648-50. 2007
  2. ncbi Gastric fundic distension activates fronto-limbic structures but not primary somatosensory cortex: a functional magnetic resonance imaging study
    Uri Ladabaum
    Division of Gastroenterology, S 357, Box 0538, University of California, San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143 0538, and The Children s Hospital of Philadelphia, PA 19104, USA
    Neuroimage 34:724-32. 2007
    ..The brain representation of visceral stimulation bears important similarities to that of somatic stimulation. However, the role of the primary (S1) and secondary (S2) somatosensory cortices in mediating gastric sensation is uncertain...
  3. ncbi Citalopram provides little or no benefit in nondepressed patients with irritable bowel syndrome
    Uri Ladabaum
    Division of Gastroenterology, University of California, San Francisco, California Department of Medicine, University of California, San Francisco, California, USA
    Clin Gastroenterol Hepatol 8:42-48.e1. 2010
    ..We assessed the benefit of citalopram and explored the relationships between symptoms, quality of life (QOL), and rectal sensitivity to barostat distension in non-depressed IBS patients...
  4. ncbi Colorectal cancer screening differential costs for younger versus older Americans
    Uri Ladabaum
    Division of Gastroenterology, University of California San Francisco, 94143 0538, USA
    Am J Prev Med 30:378-84. 2006
    ..It was therefore hypothesized that increased use of CRC screening and polypectomy in younger persons might yield CRC-related savings later in life for payers such as Medicare...
  5. ncbi Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand
    Uri Ladabaum
    Division of Gastroenterology, University of California, San Francisco, 94143, USA
    Gastroenterology 129:1151-62. 2005
    ..Our aim was to produce integrated, comprehensive estimates of the impact of widespread screening on national clinical and economic outcomes and health services demand...
  6. ncbi Trends in colonoscopy for colorectal cancer screening
    Kathryn A Phillips
    University of California, San Francisco, CA 94143, USA
    Med Care 45:160-7. 2007
    ..A major health priority is to increase colorectal cancer screening, and colonoscopy has become an increasingly important method of screening. The Medicare program began coverage for colonoscopy for average risk individuals in 2001...
  7. ncbi Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis
    Kenneth Song
    Department of Medicine, Division of Gastroenterology, University of California-San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143-0538, USA
    Gastroenterology 126:1270-9. 2004
    ..Fecal DNA testing could decrease the national CRC burden if it could improve adherence with screening, particularly where the capacity to perform screening colonoscopy is limited...
  8. ncbi Preferences for outcomes associated with decisions to undergo or forgo genetic testing for Lynch syndrome
    Miriam Kuppermann
    Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, USA
    Cancer 119:215-25. 2013
    ..Little is known, however, regarding how patients view the prospect of such testing. In addition, data on preferences (utilities) for the potential outcomes of testing decisions for use in cost-effectiveness analyses are lacking...
  9. ncbi Diagnosis, comorbidities, and management of irritable bowel syndrome in patients in a large health maintenance organization
    Uri Ladabaum
    Division of Gastroenterology, Stanford University, Stanford, California, USA
    Clin Gastroenterol Hepatol 10:37-45. 2012
    ..We aimed to characterize practice patterns for patients with IBS in a large health maintenance organization, analyzing point of diagnosis, testing, comorbidities, and treatment...
  10. ncbi Colorectal neoplasia screening with virtual colonoscopy: when, at what cost, and with what national impact?
    Uri Ladabaum
    Department of Medicine, University of California, San Francisco, 94143 0538, USA
    Clin Gastroenterol Hepatol 2:554-63. 2004
    ..We evaluated the effectiveness and cost-effectiveness of virtual colonoscopy screening (VC) vs. colonoscopy screening (COLO) and the potential impact at the national level...
  11. ncbi Can calcium chemoprevention of adenoma recurrence substitute or serve as an adjunct for colonoscopic surveillance?
    Aasma Shaukat
    Department of Medicine, Division of Gastroenterology, University of Minnesota, 406 Harvard Street SE, MMC 36, Minneapolis, Minnesota 55455, USA
    Int J Technol Assess Health Care 25:222-31. 2009
    ..The aim of this study was to examine the potential cost-effectiveness of calcium chemoprevention post-polypectomy as a substitute or adjunct for surveillance...
  12. ncbi Preferences for genetic testing to identify hereditary colorectal cancer: perspectives of high-risk patients, community members, and clinicians
    Judith Walsh
    Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, CA, USA
    J Cancer Educ 27:112-9. 2012
    ..High-risk patients, community members, and health care providers had different priorities. Health care professionals should be aware of differences between their own considerations about GT and those that are important to patients...
  13. ncbi Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis
    Derek Patel
    Division of Gastroenterology, Department of Medicine, University of California, 513 Parnassus Avenue, San Francisco, CA 94143-0538, USA
    Clin Gastroenterol Hepatol 3:75-84. 2005
    ..By increasing organ availability for timely definitive treatment, LDLT might achieve the greatest gain in life expectancy at acceptable costs. Prioritizing CLT for HCC might increase the population-wide benefits of CLT...
  14. ncbi Cost-effectiveness of 5-aminosalicylic acid therapy for maintenance of remission in ulcerative colitis
    Eugene F Yen
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco, San Francisco, California 94143 0538, USA
    Am J Gastroenterol 103:3094-105. 2008
    ..The relative benefits and costs of maintenance 5-ASA therapy are uncertain. Our aims were to evaluate this strategy's potential cost-effectiveness...
  15. ncbi Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis
    Uri Ladabaum
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California, USA
    Ann Intern Med 155:69-79. 2011
    ..Testing has been advocated for all persons with newly diagnosed colorectal cancer to identify families with the Lynch syndrome, an autosomal dominant cancer-predisposition syndrome that is a paradigm for personalized medicine...
  16. ncbi Real-time optical biopsy of colon polyps with narrow band imaging in community practice does not yet meet key thresholds for clinical decisions
    Uri Ladabaum
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California, USA
    Gastroenterology 144:81-91. 2013
    ..We prospectively evaluated real-time optical biopsy analysis of polyps with narrow band imaging (NBI) by community-based gastroenterologists...
  17. ncbi Disparities in cancer screening in individuals with a family history of breast or colorectal cancer
    Ninez A Ponce
    Department of Health Services, University of California at Los Angeles, Los Angeles, California, USA
    Cancer 118:1656-63. 2012
    ..The authors evaluated whether breast cancer (BC) and colorectal cancer (CRC) disparities varied by family history risk using a large, multiethnic population-based survey...
  18. ncbi Rates and predictors of colorectal cancer screening
    Su Ying Liang
    School of Pharmacy, University of California, San Francisco, 3333 California St, Suite 420, Box 0613, San Francisco, CA 94143, USA
    Prev Chronic Dis 3:A117. 2006
    ....
  19. ncbi Cost-effectiveness of screening for recurrent hepatocellular carcinoma after liver transplantation
    Uri Ladabaum
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco, CA 94143 0538, USA
    Clin Transplant 25:283-91. 2011
    ..Screening for two yr in only those whose explant pathology exceeds MC may be relatively cost-effective depending on the survival benefit of resection...
  20. ncbi Proximal and distal colorectal cancer resection rates in the United States since widespread screening by colonoscopy
    Parvathi A Myer
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California 94063, USA
    Gastroenterology 143:1227-36. 2012
    ..We examined US trends in rates of resection for proximal vs distal CRC, which reflect CRC incidence, in the context of national CRC screening data, before and since Medicare's 2001 decision to pay for screening colonoscopy...
  21. ncbi Potential effect of cyclooxygenase-2-specific inhibitors on the prevention of colorectal cancer: a cost-effectiveness analysis
    Uri Ladabaum
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco 94143 0538, USA
    Am J Med 114:546-54. 2003
    ..To estimate the potential cost-effectiveness of colorectal cancer chemoprevention with cyclooxygenase-2-specific inhibitors (COX-2 inhibitors)...
  22. ncbi Colonoscopic treatment of acute diverticular hemorrhage using endoclips
    Eugene F Yen
    Division of Gastroenterology, University of California, San Francisco, CA, USA
    Dig Dis Sci 53:2480-5. 2008
    ..Colonoscopy should be considered in patients with suspected acute diverticular hemorrhage, as it may enable definitive therapy without the need for more invasive treatment...
  23. ncbi The yield of lower endoscopy in patients with constipation: survey of a university hospital, a public county hospital, and a Veterans Administration medical center
    Craig Pepin
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco, California 94143, USA
    Gastrointest Endosc 56:325-32. 2002
    ..Although chronic constipation alone may not be an appropriate indication for lower endoscopy, age-appropriate colorectal cancer screening should be pursued when patients with constipation seek medical care...
  24. ncbi Sedation for gastrointestinal endoscopy: new practices, new economics
    James Aisenberg
    Mount Sinai School of Medicine, New York, USA
    Am J Gastroenterol 100:996-1000. 2005
  25. ncbi Education does pay off: pneumococcal vaccine screening and administration in hospitalized adult patients with pneumonia
    Rachel Kruspe
    Louisiana State University, Internal Medicine Department, New Orleans, USA
    J La State Med Soc 155:325-31. 2003
    ..0001). The findings from this study highlight the importance of education in increasing compliance with widely-accepted practice guidelines such as pneumococcal vaccine screening or administration in patients hospitalized with pneumonia...
  26. ncbi Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin
    C Mel Wilcox
    Department of Internal Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Clin Gastroenterol Hepatol 4:1082-9. 2006
  27. ncbi Helicobacter pylori test-and-treat intervention compared to usual care in primary care patients with suspected peptic ulcer disease in the United States
    Uri Ladabaum
    Department of Medicine, School of Public Health, Consortium for Health Outcomes, Innovation, and Cost-Effectiveness Studies (CHOICES, University of Michigan, Ann Arbor, USA
    Am J Gastroenterol 97:3007-14. 2002
    ..It remains to be determined whether increased use of the test-and-treat strategy yields significant improvements in clinical and economic outcomes compared to usual care...
  28. ncbi A patient with high risk of gastrointestinal bleeding requiring nonsteroidal anti-inflammatory drugs
    C Mel Wilcox
    Department of Medicine, Division of Gastroenterology and Hepatology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Clin Gastroenterol Hepatol 4:1090-3. 2006